Singapore, June 18 -- Lotte Biologics, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. have signed a tripartite Memorandum of Understanding (MoU) to build an ADC Toolbox for the development of antibody-drug conjugates (ADCs).

Through this agreement, the three companies will collaborate on the joint research and development of linker and payload technologies, which are key components in the development of next-generation ADC cancer therapies.

Axcelead Drug Discovery Partners, Inc., a world-class drug discovery platform Contract Research Organization (CRO) by inheriting the drug discovery platform from Takeda Pharmaceutical Company in Japan, plans to leverage a compound library comprising more than 1.2 million compoun...